Markets:

Overview

News

Currencies

International

Treasuries

uniQure N.V. - Ordinary Shares (NQ:QURE)

30.82 +0.70 (+2.32%)

Streaming Delayed Price Updated: 1:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about uniQure N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

NASDAQ: QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

November 12, 2025

Via TheNewswire.com

Topics Fraud

NASDAQ: QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

November 12, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

November 12, 2025

From Schall Law

Via GlobeNewswire

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

A Glimpse of uniQure's Earnings Potential ↗

November 07, 2025

Via Benzinga

Dow Jones Hits Record as Shutdown Deal Nears—AI Sector Feels the Heat ↗

November 12, 2025

Optimism about a possible end to the U.S. government shutdown pushed the Dow Jones to new highs, but Big Tech couldn’t keep up. Nvidia took a beating after SoftBank’s surprise exit.

Via Chartmill

Topics Stocks

uniQURE N.V. Investigation: Investors Encouraged to Contact Kirby McInerney LLP

November 11, 2025

From Kirby McInerney LLP

Via Business Wire

uniQure (QURE) Q3 2025 Earnings Call Transcript ↗

November 10, 2025

uniQure (QURE) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

November 10, 2025

From uniQure Inc.

Via GlobeNewswire

Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 10, 2025

Via Benzinga

NASDAQ: QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

November 08, 2025

Via TheNewswire.com

Topics Fraud

NASDAQ: QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

November 08, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

uniQure to Announce Third Quarter 2025 Financial Results

November 06, 2025

~ uniQure to host earnings call on Monday, November 10, 2025 at 8:30 a.m. ET ~

From uniQure Inc.

Via GlobeNewswire

Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection ↗

November 05, 2025

Biohaven stock plunged after the FDA rejected Vyglxia for spinocerebellar ataxia, prompting major R&D cuts and a William Blair downgrade.

Via Benzinga

UNIQURE ALERT: Bragar Eagel & Squire, P.C. is Investigating uniQure N.V. on Behalf of uniQure Stockholders and Encourages Investors to Contact the Firm

November 05, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

November 05, 2025

From Schall Law

Via GlobeNewswire

Biohaven Craters After FDA Unexpectedly Rejects Its High-Profile Drug ↗

November 05, 2025

The company was nearing approval for a treatment for a rare, neurodegenerative disease. Then, the FDA spoke.

Via Investor's Business Daily

Topics Earnings

Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

November 05, 2025

Via Benzinga

uniQure N.V. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (QURE)

November 04, 2025

From Kirby McInerney LLP

Via GlobeNewswire

FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy ↗

November 04, 2025

William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.

Via Benzinga

NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

November 04, 2025

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

November 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 04, 2025

Via Benzinga

Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗

November 04, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

November 03, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Which stocks are moving on Monday? ↗

November 03, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Gold Edges Higher; ISM Manufacturing PMI Falls In October ↗

November 03, 2025

Via Benzinga

UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data ↗

November 03, 2025

UniQure shares fell after the FDA questioned the adequacy of data supporting its AMT-130 gene therapy for Huntington's disease, delaying BLA plans.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.